(PharmaNewsWire.Com, May 08, 2018 ) The Cardiac Monitoring & Cardiac Rhythm Management Devices Market accounted to USD 23.22 billion in 2016 growing at a CAGR of 5.1% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Market Definition:
Cardiac monitoring is the process in which cardiac activity is examined and cardiac rhythm management is required to manage the rhythm disorders of the heart. The devices used in the treatment of serious cardiac disorders, including heart failure, atrial fibrillation, atrial flutter, indications of recent heart attack, coronary ischemia, lack of oxygen supply to cardiac muscles, effects of drugs, and certain genetic errors among others. Rise in the incidences of cardiovascular disorders and favorable government regulation and technological advancements are the vital drivers for this market.
Major Market Drivers and Restraints:
Increasing prevalence of cardiovascular diseases.
Technological advancements of cardiovascular devices.
Increasing demand of private institutional nursing and home-based
setting devices.
Stringent government regulations
Scarcity of skilled professionals with expertise in electrocardiography and cardiac monitoring.
Market Segmentation:
The north americacardiac monitoring & cardiac rhythm management devices market research is segmented on the basis of product type into cardiac monitoring and cardiac rhythm management (CRM). The cardiac monitoring segment is sub-segmented into ECG devices, implantable loop recorders, cardiac output monitoring (COM) devices, event monitors and cardiac rhythm monitoring into defibrillators, pacemakers, cardiac resynchronization therapy devices.
The ECG devices are further segmented on the basis of type and lead type. The segmentation of ECG devices on the basis of by type ECG devices includes resting ECG, stress ECG and holter monitor. Holter monitor is further segmented into wired and wireless. On the basis of lead type the market is segmented into single-lead ECG devices, 3 to 6-lead ECG devices and 12-lead ECG devices. Cardiac output monitoring devices are further segmented on the basis of type into minimally invasive COM devices and noninvasive COM devices. The event monitors segment is further sub-segmented into type and technology. On the basis of type the event monitors is segmented into pre-symptom and post-symptom and on the basis of by technology the event monitors is segmented into manual event monitors and auto-detect monitors.
The cardiac rhythm monitoring segment is segmented on the basis of type which includes defibrillators, pacemakers and cardiac resynchronization therapy devices.
By End User the market is segmented into ambulatory care centers, home care settings, cardiac surgery centers, hospitals, clinics.
This research report scopes includes the following geographical segments
United States
Canada
Mexico
Competitive Analysis:
The cardiac monitoring & cardiac rhythm management devices market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Cardiac Monitoring & Cardiac Rhythm Management Devices Market for global, Europe, North America, Asia Pacific and South America.
Top players operating in cardiac monitoring & cardiac rhythm management devices market Medtronic,
Abbott,
Boston Scientific Corporation ,
GE Company,
Koninklijke Philips N.V.,
Biotronik SE & Co.,
KG,
Mortara Instrument,
Schiller,
ABIOMED,
Hill-Rom,
NIHON KOHDEN CORPORATION,
ReliantHeart Inc.,
Siemens AG,
3M,
Berlin Heart GmbH,
This reports includes the following deliverable
Macro Indicator Analysis
Market Overview
Market Dynamics
Drivers, Restraints, Opportunities and Challenges
Market sizing and growth analysis
Market forecasting to 2024
Market Competitive Landscape
Product Launches and Pipeline Analysis
Value Chain Analysis
Market Mergers, Acquisitions and Agreements
Company Profiles
This report scope includes a holistic study of the current dynamics of the market, industry growth and restraints of the market. It provides the market forecast to 2024, recent developments in the market and pipeline analysis of the major players. The report also includes a review of micro and macro forecasts, new entrant strategies, and market penetration strategies with a comprehensive value chain analysis.
Cardiac Monitoring & Cardiac Rhythm Management Devices Market By Type (Cardiac Monitoring {ECG, Implantable Loop Recorders, COM, Event Monitors}, CRM {Defibrillators, Pacemakers, Cardiac Resynchronization Therapy}, By End User (Ambulatory Centers, Home Care, Cardiac Centers, Hospitals, Clinics), By Geography Industry Trends and Forecast to 2024
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
